Avalo Therapeutics Inc. buy BTIG Research
Start price
30.09.25
/
50%
€0.041
Target price
30.09.26
€34.13
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 30.09.26. The prediction end date can be changed by BTIG_Research at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Avalo Therapeutics Inc. | - | - |
| iShares Core DAX® | 0,79 % | 1,97 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % |
| iShares S&P 500 | 2,50 % | 2,76 % |
Comments by BTIG_Research for this prediction
In the thread Avalo Therapeutics Inc. diskutieren
Avalo Therapeutics (NASDAQ:AVTX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $40.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
Stopped prediction by BTIG_Research for Avalo Therapeutics Inc.
Avalo Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.041
13.04.26
13.04.26
€34.22
13.04.27
13.04.27
-
28.12.23
28.12.23
Avalo Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.041
24.03.26
24.03.26
€34.51
24.03.27
24.03.27
-
28.12.23
28.12.23
Avalo Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.041
19.12.24
19.12.24
€38.45
19.12.25
19.12.25
-
20.12.25
20.12.25